197 related articles for article (PubMed ID: 14533979)
1. Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities.
Hurst DR; Schwartz MA; Ghaffari MA; Jin Y; Tschesche H; Fields GB; Sang QX
Biochem J; 2004 Feb; 377(Pt 3):775-9. PubMed ID: 14533979
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K
EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659
[TBL] [Abstract][Full Text] [Related]
3. A unique substrate binding mode discriminates membrane type-1 matrix metalloproteinase from other matrix metalloproteinases.
Kridel SJ; Sawai H; Ratnikov BI; Chen EI; Li W; Godzik A; Strongin AY; Smith JW
J Biol Chem; 2002 Jun; 277(26):23788-93. PubMed ID: 11959855
[TBL] [Abstract][Full Text] [Related]
4. Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites. Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan.
Büttner FH; Hughes CE; Margerie D; Lichte A; Tschesche H; Caterson B; Bartnik E
Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):159-65. PubMed ID: 9639575
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase triple-helical peptidase activities are differentially regulated by substrate stability.
Minond D; Lauer-Fields JL; Nagase H; Fields GB
Biochemistry; 2004 Sep; 43(36):11474-81. PubMed ID: 15350133
[TBL] [Abstract][Full Text] [Related]
6. Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.
Lauer-Fields JL; Broder T; Sritharan T; Chung L; Nagase H; Fields GB
Biochemistry; 2001 May; 40(19):5795-803. PubMed ID: 11341845
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme.
Neumann U; Kubota H; Frei K; Ganu V; Leppert D
Anal Biochem; 2004 May; 328(2):166-73. PubMed ID: 15113693
[TBL] [Abstract][Full Text] [Related]
8. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
9. Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme.
Stracke JO; Hutton M; Stewart M; Pendás AM; Smith B; López-Otin C; Murphy G; Knäuper V
J Biol Chem; 2000 May; 275(20):14809-16. PubMed ID: 10809722
[TBL] [Abstract][Full Text] [Related]
10. Distinct roles of catalytic and pexin-like domains in membrane-type matrix metalloproteinase (MMP)-mediated pro-MMP-2 activation and collagenolysis.
Jiang A; Pei D
J Biol Chem; 2003 Oct; 278(40):38765-71. PubMed ID: 12878590
[TBL] [Abstract][Full Text] [Related]
11. Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase.
Kolkenbrock H; Essers L; Ulbrich N; Will H
Biol Chem; 1999 Sep; 380(9):1103-8. PubMed ID: 10543448
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the role of the "MT-loop": an eight-amino acid insertion specific to progelatinase A (MMP2) activating membrane-type matrix metalloproteinases.
English WR; Holtz B; Vogt G; Knäuper V; Murphy G
J Biol Chem; 2001 Nov; 276(45):42018-26. PubMed ID: 11555661
[TBL] [Abstract][Full Text] [Related]
13. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
[TBL] [Abstract][Full Text] [Related]
14. Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44-kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage.
Tam EM; Wu YI; Butler GS; Stack MS; Overall CM
J Biol Chem; 2002 Oct; 277(41):39005-14. PubMed ID: 12145314
[TBL] [Abstract][Full Text] [Related]
15. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
Jo Y; Yeon J; Kim HJ; Lee ST
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
[TBL] [Abstract][Full Text] [Related]
16. Mutational and structural analyses of the hinge region of membrane type 1-matrix metalloproteinase and enzyme processing.
Osenkowski P; Meroueh SO; Pavel D; Mobashery S; Fridman R
J Biol Chem; 2005 Jul; 280(28):26160-8. PubMed ID: 15901740
[TBL] [Abstract][Full Text] [Related]
17. Distinct roles for the catalytic and hemopexin domains of membrane type 1-matrix metalloproteinase in substrate degradation and cell migration.
Cao J; Kozarekar P; Pavlaki M; Chiarelli C; Bahou WF; Zucker S
J Biol Chem; 2004 Apr; 279(14):14129-39. PubMed ID: 14729674
[TBL] [Abstract][Full Text] [Related]
18. Cleavage at the stem region releases an active ectodomain of the membrane type 1 matrix metalloproteinase.
Toth M; Osenkowski P; Hesek D; Brown S; Meroueh S; Sakr W; Mobashery S; Fridman R
Biochem J; 2005 Apr; 387(Pt 2):497-506. PubMed ID: 15560752
[TBL] [Abstract][Full Text] [Related]
19. Complex pattern of membrane type 1 matrix metalloproteinase shedding. Regulation by autocatalytic cells surface inactivation of active enzyme.
Toth M; Hernandez-Barrantes S; Osenkowski P; Bernardo MM; Gervasi DC; Shimura Y; Meroueh O; Kotra LP; Gálvez BG; Arroyo AG; Mobashery S; Fridman R
J Biol Chem; 2002 Jul; 277(29):26340-50. PubMed ID: 12004057
[TBL] [Abstract][Full Text] [Related]
20. Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3).
Nagase H; Fields CG; Fields GB
J Biol Chem; 1994 Aug; 269(33):20952-7. PubMed ID: 8063713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]